Jaudoin Céline, Maue Gehrke Maria, Grillo Isabelle, Cousin Fabrice, Ouldali Malika, Arteni Ana-Andreea, Ferrary Evelyne, Siepmann Florence, Siepmann Juergen, Simeliere Fanny, Bochot Amélie, Agnely Florence
Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 17, avenue des Sciences, 91400 Orsay, France.
Institut Laue-Langevin, 71, avenue des Martyrs, 38042 Grenoble, France.
Int J Pharm. 2023 Oct 28:123560. doi: 10.1016/j.ijpharm.2023.123560.
Mixtures of hyaluronic acid (HA, in the semi-dilute entangled regime) with liposomes (high lipid concentration) exhibit a great interest in drug delivery. Considering the difference of microstructures when varying the liposome surface, we aimed to determine if liposome characteristics (surface and size) also influenced their release from these hybrid systems and to explore the mechanisms involved. Small-angle neutron scattering, cryogenic electron microscopy, zetametry, and dynamic light scattering were used to characterize liposomes. The implemented Transwell® model (two compartments separated by a polycarbonate membrane) showed that both size and surface governed liposome release. At 150 nm, anionic liposomes with or without poly(ethylene glycol) chains (PEG) migrated from HA-liposome mixtures, while cationic and neutral ones did not. Furthermore, increasing the size of PEGylated liposomes up to 200 nm or more strongly hindered their migration. Below 200 nm, the smaller the liposome size, the faster the release. Multiple and complex mechanisms (interactions between HA and liposomes, water exchanges, liposome migration, swelling and erosion, and HA reptation) were involved. Their relative importance depended on liposome characteristics. The Transwell® model is a pertinent tool to assess in vitro the release of liposomes over several weeks and discriminate the formulations, depending on the foreseen therapeutic strategy.
透明质酸(HA,处于半稀释缠结状态)与脂质体(高脂质浓度)的混合物在药物递送方面具有很大的研究价值。考虑到改变脂质体表面时微观结构的差异,我们旨在确定脂质体特性(表面和大小)是否也会影响其从这些混合体系中的释放,并探索其中涉及的机制。使用小角中子散射、低温电子显微镜、zeta电位测定法和动态光散射来表征脂质体。所采用的Transwell®模型(由聚碳酸酯膜分隔的两个隔室)表明,大小和表面都决定着脂质体的释放。在150纳米时,带有或不带有聚乙二醇链(PEG)的阴离子脂质体从HA-脂质体混合物中迁移出来,而阳离子和中性脂质体则不会。此外,将聚乙二醇化脂质体的大小增加到200纳米或更大时,会更强烈地阻碍其迁移。在200纳米以下,脂质体尺寸越小,释放速度越快。涉及多种复杂机制(HA与脂质体之间的相互作用、水交换、脂质体迁移、溶胀和侵蚀以及HA的蠕动)。它们的相对重要性取决于脂质体特性。Transwell®模型是一种相关工具,可在体外评估脂质体在数周内的释放情况,并根据预期的治疗策略区分不同的制剂。